CRO Enterprise

China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Market Successfully

&G Pharmastudies publicly issued 15,000,000 shares at a price of RMB78.88 per share, and the total amount of funds raised is expected to be RMB1.18 billion.